Product Information
MILI 0.25-0.035 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1190 per EA under NDC 65862077685. Its NADAC has been published 420 times since Aug 8, 2018.
FDA first approved this application on Jul 7, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Aurobindo Pharma LimitedNDC
65862077685
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA205449FDA Approved
7/7/2016
TE Code
AB
On Market Since
7/7/2016
Price Statistics
The NADAC for MILI 0.25-0.035 MG TABLET has been published 420 times since Aug 8, 2018, and over the history we have for it it has declined 54.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1190 per EA |
|---|---|
| All-time high | $0.2653 (Nov 14, 2018) |
| All-time low | $0.1011 (Nov 20, 2024) |
| 52-week high | $0.1336 |
| 52-week low | $0.1190 |
| Median price | $0.1523 |
| Average price | $0.1756 |
| Largest weekly change | -21.9% (Nov 20, 2024) |
| Weeks tracked | 420 |
| Tracking since | Aug 8, 2018 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MILI 0.25-0.035 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MILI 0.25-0.035 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1190 per EA (NDC 65862077685), effective Aug 19, 2026.
How has the price of MILI 0.25-0.035 MG TABLET changed over time?
Over the history we have for it, the NADAC for MILI 0.25-0.035 MG TABLET has declined 54.2%. It has been tracked across 420 weekly CMS publications since Aug 8, 2018.
What are the highest and lowest recorded NADAC prices for MILI 0.25-0.035 MG TABLET?
Since Aug 8, 2018, the NADAC for MILI 0.25-0.035 MG TABLET has ranged from a low of $0.1011 (Nov 20, 2024) to a high of $0.2653 (Nov 14, 2018), with a median of $0.1523 per EA.
Are there cheaper alternatives to MILI 0.25-0.035 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRI-LO-ESTARYLLA TABLET, is $0.1083 per EA — about 9% below MILI 0.25-0.035 MG TABLET.
Who manufactures MILI 0.25-0.035 MG TABLET?
MILI 0.25-0.035 MG TABLET (NDC 65862077685) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.